L’Oréal, Natura, Galderma test treatments for ‘Ozempic face’
L’Oréal, Galderma and Natura are testing skincare and aesthetic treatments for facial sagging and volume loss associated with rapid weight loss, as use of GLP-1 drugs creates a growing market. Experts emphasize the changes stem from rapid weight loss—not the medications themselves—and note that injectables may be more effective than topical products for restoring facial volume.
Health · 7 sources · Oct 22, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About semaglutide
Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for weight management. It can be administered by subcutaneous injection or taken orally. It is sold as a generic drug by several drug companies in the Indian and Canadian markets, and worldwide by its originator, Novo, under the brand names Ozempic and Rybelsus for diabetes; under the brand name Wegovy for weight management; and under the brand names Wegovy and Kayshild for the treatment of metabolic-associated steatohepatitis and liver cirrhosis. Wegovy is also used to reduce the risk of heart attacks.
Everything about semaglutide →